RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells

Bone marrow-derived mesenchymal stem cells (MSCs) contribute to breast cancer progression by releasing soluble factors that sustain tumor progression. MSCs express functional epidermal growth factor receptor (EGFR) and breast cancer cells secrete EGFR-ligands including transforming growth factor-alpha (TGF alpha). Using RNA-sequencing, we analysed the whole transcriptome of MSCs stimulated with TGF alpha. We identified 1,640 highly differentially regulated genes: 967 genes up-regulated with Fold Induction (FI)>= 1.50 and 673 genes down-regulated with FI <= 0.50. When highly regulated genes were categorized according to GO molecular function classification and KEGG pathways analysis, a large number of genes coding for potentially secreted proteins or surface receptors resulted enriched following TGF alpha treatment, including VEGFA, IL6, EREG, HB-EGF, LIF, NGF, NRG1, CCL19, CCL2, CCL25 and CXCL3. Secretion of corresponding proteins was confirmed for selected factors. Finally, we identified 4,377 and 4,262 alternatively spliced genes in untreated and TGF alpha-treated MSCs, respectively. Among these, an unannotated splice variant of VEGFA coding for a secreted VEGF protein of 172 aminoacids (VEGFA(172)), was found only in MSCs stimulated with TGF alpha. These findings suggest that EGFR activation in MSCs leads to a significant change in the expression of a wide array of genes coding for secreted proteins that can significantly enhance tumor progression.